Košík
zboží
(prázdné)
Kontakt
Účet
MEGA VÝHODNÉ
This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of...
číst celé
This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.
schovat popis- Nakladatel: Peter Lang AG
- Kód:
- Rok vydání: 2015
- Jazyk: Angličtina
- Vazba: Vázaná
- Počet stran: 201
- Šířka balení: 21.5 cm
- Výška balení: 15.4 cm
- Hloubka balení: 1.7 cm
- Váha balení: 362 g
Recenze